文献速递认知障碍与痴呆

红细胞ω-3脂肪酸与中年期MRI标志物及认知功能的关联:弗雷明汉心脏研究

Association of Red Blood Cell Omega-3 Fatty Acids With MRI Markers and Cognitive Function in Midlife: The Framingham Heart Study.
PubMed 文献 · Neurology · 2022-12-05

基于弗雷明汉心脏研究第三代与Omni 2队列的横断面分析纳入2183名无痴呆、无卒中参与者(平均年龄46岁,53%女性,22%为APOE-e4携带者),发现较高的ω-3指数与较大的海马体积及较好的抽象推理能力相关,且这些关联因APOE基因型而异;作者称结果属探索性,需在中年人群中进一步研究确认。

要点

  • ω-3指数每升高1个标准差,海马体积β=0.003±0.001(p=0.013),抽象推理β=0.17±0.07(p=0.013)。
  • APOE-e4非携带者中DHA或ω-3指数较高与海马体积较大相关,携带者中EPA较高与抽象推理较好相关。
  • 仅在APOE-e4携带者中,较高的各类ω-3指标与较低的白质高信号负荷相关。

核心结论

  • 作者认为,在主要为中年、无临床痴呆的队列中,较高的ω-3脂肪酸浓度与较好的脑结构和认知功能相关,结果属探索性,并提示这种关联可能因APOE基因型而不同。
  • 作者指出,需要在中年人群中开展更多研究以确认这些发现。

研究设计与样本

  • 弗雷明汉心脏研究第三代与Omni 2队列参加第二次检查的参与者,共纳入2183名无痴呆、无卒中者(平均年龄46岁,53%女性,22%为APOE-e4携带者)。
  • 用气相色谱法测定红细胞DHA与EPA浓度,ω-3指数按EPA+DHA计算。
  • 采用线性回归模型分析ω-3脂肪酸浓度与脑MRI指标(总脑、总灰质、海马、白质高信号体积)及认知功能(情景记忆、加工速度、执行功能、抽象推理)的横断面关联,并校正潜在混杂因素。
  • 进一步检验ω-3脂肪酸水平与APOE基因型(e4携带者与非携带者)对MRI和认知结局的交互作用。

主要发现

  • 较高的ω-3指数与较大的海马体积相关(标准差单位β±标准误:0.003±0.001,p=0.013),并与较好的抽象推理相关(0.17±0.07,p=0.013)。
  • DHA或EPA浓度单独分析时获得类似结果。
  • 按APOE-e4状态分层:在APOE-e4非携带者中,较高的DHA浓度或ω-3指数与较大的海马体积相关;在APOE-e4携带者中,较高的EPA浓度与较好的抽象推理相关。
  • 仅在APOE-e4携带者中,较高的各类ω-3指标水平与较低的白质高信号负荷相关。

局限性

  • 作者称结果为探索性(albeit exploratory)。
  • 作者指出需要在中年人群中开展更多研究以确认这些发现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Diet may be a key contributor to brain health in midlife. In particular, omega-3 fatty acids have been related to better neurologic outcomes in older adults. However, studies focusing on midlife are lacking. We investigated the cross-sectional association of red blood cell (RBC) omega-3 fatty acid concentrations with MRI and cognitive markers of brain aging in a community-based sample of predominantly middle-aged adults and further explore effect modification by APOE genotype. METHODS: We included participants from the Third-Generation and Omni 2 cohorts of the Framingham Heart Study attending their second examination. Docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) concentrations were measured from RBC using gas chromatography, and the Omega-3 index was calculated as EPA + DHA. We used linear regression models to relate omega-3 fatty acid concentrations to brain MRI measures (i.e., total brain, total gray matter, hippocampal, and white matter hyperintensity volumes) and cognitive function (i.e., episodic memory, processing speed, executive function, and abstract reasoning) adjusting for potential confounders. We further tested for interactions between omega-3 fatty acid levels and APOE genotype (e4 carrier vs noncarrier) on MRI and cognitive outcomes. RESULTS: We included 2,183 dementia-free and stroke-free participants (mean age of 46 years, 53% women, 22% APOE-e4 carriers). In multivariable models, higher Omega-3 index was associated with larger hippocampal volumes (standard deviation unit beta ±standard error; 0.003 ± 0.001, p = 0.013) and better abstract reasoning (0.17 ± 0.07, p = 0.013). Similar results were obtained for DHA or EPA concentrations individually. Stratification by APOE-e4 status showed associations between higher DHA concentrations or Omega-3 index and larger hippocampal volumes in APOE-e4 noncarriers, whereas higher EPA concentrations were related to better abstract reasoning in APOE-e4 carriers. Finally, higher levels of all omega-3 predictors were related to lower white matter hyperintensity burden but only in APOE-e4 carriers. DISCUSSION: Our results, albeit exploratory, suggest that higher omega-3 fatty acid concentrations are related to better brain structure and cognitive function in a predominantly middle-aged cohort free of clinical dementia. These associations differed by APOE genotype, suggesting potentially different metabolic patterns by APOE status. Additional studies in middle-aged populations are warranted to confirm these findings.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Satizabal CL, Himali JJ, Beiser AS, et al. Association of Red Blood Cell Omega-3 Fatty Acids With MRI Markers and Cognitive Function in Midlife: The Framingham Heart Study. Neurology. 2022. PMID: 36198518. doi:10.1212/WNL.0000000000201296

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。